Physician Awareness and Understanding of Primary Immunodeficiency Disorder: A Web-based Study

Physician Awareness and Understanding of Primary Immunodeficiency Disorder: A Web-based Study - PID-JAPAN physician survey study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043088

Enrollment

350

Registered

2021-01-22

Start date

2021-01-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Immunodeficiency Disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Physicians registered to Nikkei BP panel. 2)Physicians certified by medical societies as; General internal medicine and/or Pediatrics and/or Hematology.

Exclusion criteria

Exclusion criteria: 1) Have less than 2 year of practice excluding training period 2) Work in a facility other than clinics, university hospitals, general hospitals and; national and public hospitals 3) Currently treating 0 outpatients and inpatients

Design outcomes

Primary

Measure	Time frame
To determine the level of awareness of PID and understanding the diagnostic flow in PID in clinical practice	—

Secondary

Measure	Time frame
To determine the DDx between PID w/o IgG deficits including current treatment of PID To determine the awareness and usefulness of TIPs(10 warning signs) to consider PID in clinical settings.	—

Countries

Japan

Contacts

Public ContactAkinori Oh

Takeda Pharmaceutical Company Limited Japan Medical Office

akinori.oh@takeda.com080-2413-7663

Outcome results